3.8(top 10%)
impact factor
3.4K(top 5%)
papers
53.2K(top 5%)
citations
79(top 10%)
h-index
4.1(top 10%)
impact factor
3.8K
all documents
56.3K
doc citations
125(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1The epidemiology of venous thromboembolismJournal of Thrombosis and Thrombolysis2016749
2COVID-19 update: Covid-19-associated coagulopathyJournal of Thrombosis and Thrombolysis2020529
3Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trialJournal of Thrombosis and Thrombolysis1995393
4Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forumJournal of Thrombosis and Thrombolysis2020362
5Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2Journal of Thrombosis and Thrombolysis2021359
6The Epidemiology of Venous Thromboembolism in the Community: Implications for Prevention and ManagementJournal of Thrombosis and Thrombolysis2006313
7Guidance for the treatment and prevention of obstetric-associated venous thromboembolismJournal of Thrombosis and Thrombolysis2016306
8Remodeling the Blood Coagulation CascadeJournal of Thrombosis and Thrombolysis2003277
9Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatmentJournal of Thrombosis and Thrombolysis2016272
10Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarctionJournal of Thrombosis and Thrombolysis2012258
11Guidance for the treatment of deep vein thrombosis and pulmonary embolismJournal of Thrombosis and Thrombolysis2016243
12Thrombolytic therapy in pregnancyJournal of Thrombosis and Thrombolysis2006240
13Incidence and cost burden of post-thrombotic syndromeJournal of Thrombosis and Thrombolysis2009230
14Guidance for the evaluation and treatment of hereditary and acquired thrombophiliaJournal of Thrombosis and Thrombolysis2016230
15COVID-19-associated vasculitis and vasculopathyJournal of Thrombosis and Thrombolysis2020222
16Pharmacogenetics of warfarin: regulatory, scientific, and clinical issuesJournal of Thrombosis and Thrombolysis2008216
17COVID-19 and ischemic stroke: a systematic review and meta-summary of the literatureJournal of Thrombosis and Thrombolysis2020214
18Drug and dietary interactions of warfarin and novel oral anticoagulants: an updateJournal of Thrombosis and Thrombolysis2011211
19Neutrophil extracellular traps and thrombosis in COVID-19Journal of Thrombosis and Thrombolysis2021201
20Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE studyJournal of Thrombosis and Thrombolysis2009198
21Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factorsJournal of Thrombosis and Thrombolysis2020198
22Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective studyJournal of Thrombosis and Thrombolysis2006189
23Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumoniaJournal of Thrombosis and Thrombolysis2020174
24Guidance for the prevention and treatment of cancer-associated venous thromboembolismJournal of Thrombosis and Thrombolysis2016169
25Assessing bleeding risk in patients taking anticoagulantsJournal of Thrombosis and Thrombolysis2013165
26Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitorJournal of Thrombosis and Thrombolysis2011163
27Quality Assessment of Anticoagulation Dose Management: Comparative Evaluation of Measures of Time-in-Therapeutic RangeJournal of Thrombosis and Thrombolysis2003159
28Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolismJournal of Thrombosis and Thrombolysis2016156
29Thrombolysis and Counterpulsation to Improve Survival in Myocardial Infarction Complicated by Hypotension and Suspected Cardiogenic Shock or Heart Failure: Results of the TACTICS TrialJournal of Thrombosis and Thrombolysis2005149
30Heparin resistance in COVID-19 patients in the intensive care unitJournal of Thrombosis and Thrombolysis2020145
31Clinical Features of Emergency Department Patients Presenting with Symptoms Suggestive of Acute Cardiac Ischemia: A Multicenter StudyJournal of Thrombosis and Thrombolysis1998143
32Sepsis and Disseminated Intravascular CoagulationJournal of Thrombosis and Thrombolysis2003143
33The association between treatment with heparin and survival in patients with Covid-19Journal of Thrombosis and Thrombolysis2020140
34Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitorJournal of Thrombosis and Thrombolysis2011136
35A guide to venous thromboembolism risk factor assessmentJournal of Thrombosis and Thrombolysis2000134
36Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-managementJournal of Thrombosis and Thrombolysis2000133
37Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysisJournal of Thrombosis and Thrombolysis2020133
38Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM)Journal of Thrombosis and Thrombolysis2007131
39Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trialsJournal of Thrombosis and Thrombolysis2012131
40Guidance for the prevention and treatment of the post-thrombotic syndromeJournal of Thrombosis and Thrombolysis2016131
41Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assayJournal of Thrombosis and Thrombolysis2011129
42Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patientsJournal of Thrombosis and Thrombolysis2020127
43Current status on plasma biomarkers for acute mesenteric ischemiaJournal of Thrombosis and Thrombolysis2012124
44Evolving Concepts in the Triad of Atherosclerosis, Inflammation and ThrombosisJournal of Thrombosis and Thrombolysis2004123
45Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart DiseaseJournal of Thrombosis and Thrombolysis1998115
46Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for cliniciansJournal of Thrombosis and Thrombolysis2017114
47Statins, inflammation and deep vein thrombosis: a systematic reviewJournal of Thrombosis and Thrombolysis2012113
48Worldwide Management of Oral Anticoagulant Therapy: the ISAM StudyJournal of Thrombosis and Thrombolysis2006111
49Pharmacology of anticoagulants used in the treatment of venous thromboembolismJournal of Thrombosis and Thrombolysis2016108
50Ischemic preconditioning may be transferable via whole blood transfusion: preliminary evidenceJournal of Thrombosis and Thrombolysis1999106